LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

Inicio・Lista de Acciones・Becton Dickinson and Co

Becton Dickinson and Co

Cerrado

Sector Salud

236.97 1.88

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

231.98

Máximo

238.89

Métricas clave
By Trading Economics
Ingresos	-50M 487M
Ventas	10M 5.1B
P/B Media del Sector	50.04 103.001
BPA	3.5
Margen de beneficio	9.625
Empleados	73,000
EBITDA	-124M 1.2B

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+20.64 upside

Dividendos
By Dow Jones
Próximas Ganancias	7 nov 2024
Fecha Próximo Dividendo	30 sept 2024
Próxima Fecha de Ex Dividendo	9 sept 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	70B
Apertura anterior	235.09
Cierre anterior	236.97

Noticias sobre sentimiento de mercado

By Acuity

95%

1 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

N/A / 236.38 Soporte y Resistencia

Becton Dickinson and Co Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

1 ago 2024, 11:08 UTC

Ganancias

Becton 3Q Adjusted Earnings Top Views But International Sales Weigh on FY24 Outlook

3 jun 2024, 11:18 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash

2 may 2024, 11:07 UTC

Ganancias

Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings

1 ago 2024, 10:37 UTC

Ganancias

Becton Dickinson Now Sees FY24 Revenue About $20.1B; Had Seen $20.1B-$20.3B >BDX

1 ago 2024, 10:35 UTC

Ganancias

Becton Dickinson Sees FY24 Revenue Up About 3.7%, Organic Revenue Up 5%-5.25% >BDX

1 ago 2024, 10:35 UTC

Ganancias

Becton Dickinson Sees FY24 Adj EPS $13.05-Adj EPS $13.15 >BDX

1 ago 2024, 10:30 UTC

Ganancias

Becton Dickinson 3Q EPS $1.68 >BDX

1 ago 2024, 10:30 UTC

Ganancias

Becton Dickinson 3Q Net $487M >BDX

1 ago 2024, 10:30 UTC

Ganancias

Becton Dickinson 3Q Adj EPS $3.50 >BDX

1 ago 2024, 10:30 UTC

Ganancias

Becton Dickinson 3Q Rev $5B >BDX

4 jun 2024, 17:26 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 jun 2024, 15:30 UTC

Acciones populares

Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ

3 jun 2024, 13:26 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 jun 2024, 12:25 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 jun 2024, 11:03 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 jun 2024, 10:40 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 jun 2024, 10:32 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 jun 2024, 10:31 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 jun 2024, 10:31 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 jun 2024, 10:30 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 jun 2024, 10:30 UTC

Adquisiciones, fusiones, absorciones

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

2 may 2024, 10:35 UTC

Ganancias

Becton Dickinson Had Seen FY24 Adjusted EPS $12.82-$13.06 >BDX

2 may 2024, 10:34 UTC

Ganancias

Becton Dickinson Raises FY24 View To Adj EPS $12.95-Adj EPS $13.15 >BDX

2 may 2024, 10:34 UTC

Ganancias

Becton Dickinson Still Sees FY24 Organic Revenue Growth of 5.5%-6.25% >BDX

2 may 2024, 10:33 UTC

Ganancias

Becton Dickinson Had Seen FY24 Revenue $20.2B-$20.4B >BDX

2 may 2024, 10:33 UTC

Ganancias

Becton Dickinson Cuts FY24 View To Rev $20.1B-$20.3B >BDX

2 may 2024, 10:30 UTC

Ganancias

Becton Dickinson 2Q Net $537M >BDX

2 may 2024, 10:30 UTC

Ganancias

Becton Dickinson 2Q Adj EPS $3.17 >BDX

2 may 2024, 10:30 UTC

Ganancias

Becton Dickinson 2Q EPS $1.85 >BDX

2 may 2024, 10:30 UTC

Ganancias

Becton Dickinson 2Q Rev $5B >BDX

Comparación entre iguales

Cambio de precio

Becton Dickinson and Co Esperado

Precio Objetivo

By TipRanks

20.64% repunte

Estimación a 12 meses

Media 280.7 USD 20.64%

Máximo 312 USD

Mínimo 255 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Becton Dickinson and Co Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

11 ratings

Comprar

Mantener

Vender

De acuerdo con 11 analistas que ofrecen calificaciones bursátiles a para Becton Dickinson and Co Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

N/A / 236.38Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bearish.

Sentimiento

By Acuity

1 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.